Beyond PARP1, PARP14 directly promotes aerobic glycolysis (the Warburg effect) in hepatocellular carcinoma by modulating PKM2, linking ADP-ribosylation to pro-tumor glycolytic bias [175]. The gene discussed is PARP14; the disease is hepatocellular carcinoma.